Products

Current Location£ºProducts in IDL Application

Budenofalk£¨Budesonide£©

The active ingredient is Budesonide, and two dosage forms of Rectal Foam and Capsules are available. At present, approval letters of both products for clinical trials have been received.

Budesonide Enteric Capsules

Drug Name:

Budesonide Enteric Capsules

Indication:

For the treatment of acute mild to moderate Crohn¡¯s disease affecting the ileum and / or the ascending colon.

Registration Progress£º

Approval for clinical trial.

Budesonide Rectal Foam

Drug Name:

Budesonide Rectal Foam

Indication:

For the acute treatment of active ulcerative colitis that is limited to the rectum and the sigmoid colon.

Registration Progress£º

Approval for clinical trial.